24 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp06615 | LA3IK | LAIAVK | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 223.6 ± 5.62 µM |
| dbacp06616 | LA3IK | LAIAVK | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MCF-7 | Breast Cancer | IC50 = 90.23 ± 7.32 µM |
| dbacp06617 | LA3IK | LAIAVK | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | PC-3 | Prostate Cancer | IC50 = 321.4 ± 11.79 µM |
| dbacp06618 | LA3IK | LAIAVK | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | DU-145 | Prostate Cancer | IC50 = 335.7 ± 3.09 µM |
| dbacp06619 | D-LA3IK | laiavk | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 197.72 ± 5.42 µM |
| dbacp06620 | D-LA3IK | laiavk | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MCF-7 | Breast Cancer | IC50 = 91.2 ± 8.21 µM |
| dbacp06621 | D-LA3IK | laiavk | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | PC-3 | Prostate Cancer | IC50 = 98.71 ± 6.17 µM |
| dbacp06622 | D-LA3IK | laiavk | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | DU-145 | Prostate Cancer | IC50 = 89.11 ± 8.12 µM |
| dbacp06623 | LA3IK-SCR | LAKAVI | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 243 ± 8.16 µM |
| dbacp06624 | LA3IK-SCR | LAKAVI | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MCF-7 | Breast Cancer | IC50 = 133 ± 9.52 µM |
| dbacp06625 | LA3IK-SCR | LAKAVI | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | PC-3 | Prostate Cancer | IC50 = 319 ± 13.64 µM |
| dbacp06626 | LA3IK-SCR | LAKAVI | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | DU-145 | Prostate Cancer | IC50 = 351.76 ± 7.18 µM |
| dbacp06627 | RP-7 | RPPCVIL | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 139.03 ± 8.41 µM |
| dbacp06628 | RP-7 | RPPCVIL | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MCF-7 | Breast Cancer | IC50 = 110.12 ± 4.23 µM |
| dbacp06629 | RP-7 | RPPCVIL | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | PC-3 | Prostate Cancer | IC50 = 113 ± 8.02 µM |
| dbacp06630 | RP-7 | RPPCVIL | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | DU-145 | Prostate Cancer | IC50 = 120.72 ± 7.08 µM |
| dbacp06631 | D-RP-7 | rppcvil | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 95 ± 7.71 µM |
| dbacp06632 | D-RP-7 | rppcvil | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MCF-7 | Breast Cancer | IC50 = 90 ± 10.31 µM |
| dbacp06633 | D-RP-7 | rppcvil | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | PC-3 | Prostate Cancer | IC50 = 101 ± 5.73 µM |
| dbacp06634 | D-RP-7 | rppcvil | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | DU-145 | Prostate Cancer | IC50 = 121.59 ± 6.56 µM |
| dbacp06635 | RP7 SCR | RPPLVIC | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 156 ± 8.15 µM |
| dbacp06636 | RP7 SCR | RPPLVIC | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MCF-7 | Breast Cancer | IC50 = 150 ± 10.32 µM |
| dbacp06637 | RP7 SCR | RPPLVIC | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | PC-3 | Prostate Cancer | IC50 = 128 ± 11.65 µM |
| dbacp06638 | RP7 SCR | RPPLVIC | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | DU-145 | Prostate Cancer | IC50 = 137 ± 5.98 µM |